|A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily||
||828||All||18 Years and older (Adult, Senior)||NCT01227824||113086||SPRING-2||October 19, 2010||February 6, 2012||December 27, 2016||October 25, 2010||March 12, 2018||June 23, 2014||
|2||NCT02384395||Recruiting||Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection||
||Other / Industry||
||40||All||18 Years and older (Adult, Senior)||NCT02384395||14-0549||PHI 05||September 2015||July 2021||July 2021||March 10, 2015||April 10, 2018||
† Study has passed its completion date and status has not been verified in more than two years.